NEW YORK (GenomeWeb News) – The National Institute of Neurological Disorders and Stroke is considering how next-generation genome sequencing (NGS) will be applied in studies of neurological disorders, and is asking researchers in this area for information about how they plan to use the latest sequencing tools and genomic data in their work.
To find out how researchers aim to use next-gen whole genome sequencing (WGS), and what the needs are for sequencing, data storage, analysis, and annotation services, NINDS has released a new request for information seeking feedback from the extramural research community.
NINDS will use this feedback to inform and complement its efforts to assess the current and future whole genome sequencing needs of researchers studying a wide range of neurologic disease, and conducting basic research into the nervous system, the genetics of the brain, cognition, brain plasticity, neural signaling, learning, memory, motor control, and other areas.
"Since the technologic advancements in NGS have been rapid, the volume and complexity of the information captured through NGS challenges the storage and processing capabilities of many laboratories and institutions," NINDS said in the RFI.
To find out more about how those challenges should be met, NINDS wants researchers in the extramural community to describe what whole genome sequencing services are available at their institutions and which ones are planned, to describe the makeup of their research cohorts that will use whole genome sequencing, and to discuss how they expect WGS to contribute to their research areas.
The institute also wants to find out why researchers are seeking to use WGS instead of whole exome sequencing, what their sample requirements are expected to be, what kind of storage capacity they have at hand, how many samples they expect to sequence in the coming year, and what plans their labs have for handling and storing whole genome sequencing data.